HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sally Beauty hire

This article was originally published in The Rose Sheet

Executive Summary

Borders Inc. exec Michael Spinozzi appointed president of Sally Beauty Supply for the U.S. and Canada, charged with directing "store operations, merchandising/purchasing, advertising, customer service, customer relationship marketing" and other responsibilities, Alberto-Culver company announces June 5. Exec also will be responsible for directing the overall strategic direction for more than 2,100 Sally Beauty stores in the U.S. and Canada, firm notes. Spinozzi will report to Gary Winterhalter, president of Sally Beauty and Beauty Systems Group. Exec most recently served as exec VP, Chief Product Officer for Borders. Alberto will decide by its July board meeting whether to split Sally Beauty and Beauty Systems Group divisions from the firm's consumer products unit (1"The Rose Sheet" May 8, 2006, p. 6)...

You may also be interested in...



Alberto-Culver Weighs Options For Beauty Supply Division

Alberto-Culver will decide by its July board meeting whether to split the Sally Beauty and Beauty Systems Group divisions from the consumer products unit, President and CEO Howard Bernick stated during an April 27 analyst meeting

Could ICER Outreach To US FDA Lead To Better Cost Effectiveness Analyses?

To aid its value assessments, ICER is interested in helping FDA understand the importance of patient-relevant outcomes and consistent endpoints across trials of drugs for the same disease.

Seretide Settlement To Lift Glenmark’s Europe Business

Glenmark can sell its partnered generic rival to GSK’s Seretide Accuhaler dry powder inhaler in certain European markets following a settlement with the UK company. The Indian firm has also shelved divestment plans for its API business, at least for now.

UsernamePublicRestriction

Register

RS014004

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel